Neoplasms, Endometrial Neoplasms, Advanced Solid Tumor - Ovarian Cancer - France - Phase 2

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Showing clinical trials for Neoplasms, Endometrial Neoplasms, Advanced Solid Tumor matching location: France. I can help you find clinical trials in specific locations and provide insights on health conditions and treatments. With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

Showing clinical trials for Neoplasms, Endometrial Neoplasms, Advanced Solid Tumor matching location: France.

I can help you find clinical trials in specific locations and provide insights on health conditions and treatments.

With advanced mode, access powerful pre-screening tools, interactive data visualizations, customized email alerts for trial updates and more.

Study Title	Status
Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) NCT04956640	Recruiting
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2) (panSOHO) NCT06760819	Recruiting
First-in-Human Study of STX-478 as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors (PIKALO-1) NCT05768139	Recruiting
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) NCT05489211	Recruiting
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors NCT06172478	Recruiting
A Study of T-DXd for the Treatment of Solid Tumors Harboring HER2 Activating Mutations (DPT01) NCT04639219	Active, not recruitingResults Posted
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors NCT04657068	Recruiting
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas NCT04104776	Recruiting
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE) NCT04585750	Recruiting
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors NCT06128551	Recruiting

Clinical Trial Radar